Simple Science

Cutting edge science explained simply

# Biology # Physiology

Cleaning the Heart: A New Hope for Diabetic Heart Disease

Research reveals potential treatment targeting sugar buildup in diabetic hearts.

K M. Mellor, U. Varma, P. Koutsifeli, C.L. Curl, J.V. Janssens, L.J. Daniels, G.B. Bernasochi, A.J.A. Raaijmakers, M. Annandale, X. Li, S.L. James, D.J. Taylor, K. Raedschelders, K.L. Weeks, R.J. Mills, R.G. Parton, X. Hu, J.R. Bell, E.R. Porrello, J.E. Hudson, R-P. Xiao, J.E. Van Eyk, R.A. Gottlieb, L.M.D. Delbridge

― 5 min read


Hope for Diabetic Heart Hope for Diabetic Heart Patients hearts. New insights into sugar management in
Table of Contents

Diabetic heart disease is a specific type of heart problem that often occurs in people with diabetes. This disease affects how the heart works, particularly how it relaxes between beats. When the heart does not relax properly, it can lead to heart failure over time. In simple terms, think of it like a sponge that gets less and less springy. It’s a real bummer for those who have it.

What Happens in the Heart?

In diabetic heart disease, the heart's cells, known as cardiomyocytes, have trouble communicating and functioning well. This communication breakdown is influenced by diabetes. To understand it better, imagine a team of workers in a factory who get confused about their tasks, leading to a decrease in productivity.

One major issue in these heart cells is something called Diastolic Dysfunction. This is when the heart struggles to fill with blood because it can’t relax properly. If this keeps happening, it can lead to a serious condition called heart failure. Despite the importance of this issue, scientists are still trying to figure out exactly why this happens in diabetic patients.

The Role of Autophagy

Now, let's talk about autophagy. This is a fancy word for a process where cells clean up and recycle their parts. It's like spring cleaning for the body! When parts of cells are damaged or not needed anymore, autophagy helps get rid of them and makes way for fresh new cells.

Autophagy is crucial for maintaining healthy heart function. In diabetes, this cleaning process can get messed up. Researchers first noticed that autophagy was related to heart issues over a decade ago. They observed that specific proteins involved in autophagy were not working correctly in diabetic hearts.

In hearts affected by diabetes, scientists have found that the process of breaking down and recycling cellular materials is not working as it should. Autophagy receptors-proteins that play a role in identifying and tagging the components that need to be cleaned up-are crucial here. There’s even a receptor called STBD1 that helps to identify Glycogen-a form of stored sugar-in the heart.

Glycogen: The Sugar Stash

Glycogen is like a pantry for the heart, storing energy in the form of sugar. Normally, this stored energy is important for the heart to function well. It’s especially vital when the heart is working hard, such as during exercise.

However, diabetes can cause the heart to accumulate too much glycogen. This buildup is confusing since it doesn’t occur in other muscles like the ones in your arms and legs. It’s almost like your heart is hoarding snacks while the rest of your body is on a diet.

In diabetic hearts, scientists have found that glycogen levels increase significantly. This excess glycogen is mainly linked with the heart's mitochondria, which are the powerhouses of the cell. So imagine all that sugar crowding around the heart’s energy factories-definitely not a good situation!

The Troubles of Glycophagy

One related process is called glycophagy, which specifically refers to the breakdown of glycogen. It’s like having a special trash compactor just for those leftover sugar snacks in the heart. Researchers have found that glycophagy is not working as it should in diabetic hearts. This disruption in cleaning up excess sugar can lead to heart problems.

To put it simply, when glycophagy is faulty, the heart can’t get rid of the extra sugar, which can lead to stiff, unresponsive heart muscles. This stiffening can make it really hard for the heart to relax and pump properly.

Investigating the Problem

Researchers wanted to see if improving glycophagy in diabetic hearts could help. They focused on a specific protein called GABARAPL1. This protein is a partner to STBD1 and helps with the recycling process of glycogen in the heart.

To test this idea, scientists modified genes in the hearts of diabetic mice. They hoped that by increasing GABARAPL1 in these mice, they could help their hearts function better, reduce the glycogen buildup, and ultimately ease the diastolic dysfunction.

The Results of Gene Therapy

Scientists started experiments on diabetic mice by delivering the gene for GABARAPL1 directly to their hearts. They used a special virus to carry this gene, like a little delivery truck bringing the parcel straight to the heart.

What did they find? After treatment, the hearts of these mice showed a remarkable improvement. The level of glycogen dropped back to more normal levels, and the relaxing problem got better too. It was like a magic show where the heart went from confused and overloaded to a lean, mean, pumping machine!

Testing in Human Models

Taking their findings a step further, researchers decided to try the same approach using human stem cell-derived heart tissues, known as cardiac organoids. When they involved these human tissues, they still used the gene delivery method to see if GABARAPL1 could also help them.

Just as before, the human organoids showed improvements. The sugar overload was reduced, and the heart’s ability to relax improved too. If hearts made from human cells could respond positively like this, there's hope for future treatments.

Conclusion and Future Directions

These findings suggest that targeting glycophagy, especially through boosting the levels of GABARAPL1, could be an effective way to treat diabetic heart disease. It’s a promising area of research that could lead to new therapies in the future.

However, this is just the beginning. Researchers need to continue studying how this process works in different types of heart disease. We should also think about how factors like gender might affect glycophagy-why should guys have all the fun, right?

In summary, the heart has its own ways of dealing with sugar overload, and by understanding and treating these processes, we might just be able to help many people with diabetic heart problems lead healthier lives. Who knew that cleaning out the pantry could be so important?

Original Source

Title: Targeted glycophagy ATG8 therapy for diabetic heart disease

Abstract: Diabetic heart disease is highly prevalent1 and is associated with the early development of impaired diastolic relaxation.1 The mechanisms of diabetic heart disease are poorly understood and it is a condition for which there are no targeted therapies. Recently, disrupted glycogen-autophagy (glycophagy) and glycogen accumulation have been identified in the diabetic heart.2 Glycophagy involves glycogen receptor binding and linking with an ATG8 protein to locate and degrade glycogen within an intracellular phago-lysosome.3,4 Here we show that glycogen receptor protein STBD1 (starch-binding-domain-protein-1) is mobilized early in the cardiac glycogen response to metabolic challenge in vivo, and that deficiency of a specific ATG8 linking protein, Gabarapl1 ({gamma}-aminobutyric-acid-receptor-associated-protein-like-1) is associated with diastolic dysfunction in diabetes. Gabarapl1 gene delivery treatment remediated cardiomyocyte and cardiac diastolic dysfunction in type 2 diabetic mice and diastolic performance of diabetic human iPSC-derived cardiac organoids. We identify glycophagy dysregulation as a mechanism and potential treatment target for diabetic heart disease.

Authors: K M. Mellor, U. Varma, P. Koutsifeli, C.L. Curl, J.V. Janssens, L.J. Daniels, G.B. Bernasochi, A.J.A. Raaijmakers, M. Annandale, X. Li, S.L. James, D.J. Taylor, K. Raedschelders, K.L. Weeks, R.J. Mills, R.G. Parton, X. Hu, J.R. Bell, E.R. Porrello, J.E. Hudson, R-P. Xiao, J.E. Van Eyk, R.A. Gottlieb, L.M.D. Delbridge

Last Update: 2024-12-03 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.11.28.625926

Source PDF: https://www.biorxiv.org/content/10.1101/2024.11.28.625926.full.pdf

Licence: https://creativecommons.org/licenses/by-nc/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

More from authors

Similar Articles